Kris V. Kowdley

机构：Washington State University Spokane, Liver Institute Northwest, Velocity Clinical Research (United States), Washington State University, Georgia Highlands College · ORCID：0000-0002-8553-3652

发表论文 1038 篇 · 总被引 68834 次 · h-index 120

代表论文

• Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial (2026 · The Lancet · 被引 11)
• Seladelpar Improved Itch, Itch‐Related Sleep Disturbance and Measures of Fatigue in Patients With Primary Biliary Cholangitis and Pruritus in the Phase 3 RESPONSE Trial (2026 · Alimentary Pharmacology & Therapeutics · 被引 5)
• The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view (2026 · Nature Reviews Gastroenterology & Hepatology · 被引 3)
• EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world evidence in primary biliary cholangitis (2026 · Journal of Hepatology · 被引 2)
• Baseline Alkaline Phosphatase Impacts Response Rates in Primary Biliary Cholangitis: Exploring Response to Elafibranor in ELATIVE (2026 · Liver International · 被引 2)
• A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitis (2026 · Hepatology Communications · 被引 2)